Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans
Phytomedicine · 2025-11 · 148 · 157265
DOI: 10.1016/j.phymed.2025.157265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Xiangcheng Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Center for Membrane Receptor and Brain Medicine, The Fourth Affiliated Hospital of School of Medicine, and International Scho…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Biofilms, Candida albicans, Masoprocol. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Zhejiang University.
Abstract (Originalsprache)
INTRODUCTION: The global rise of antimicrobial resistance (AMR), particularly among biofilm-forming bacteria and fungi, has created an urgent need for novel therapeutics. Nordihydroguaiaretic acid (NDGA), a plant-derived polyphenolic lignan, has demonstrated promising biological activities, yet its potential as a dual-action antimicrobial agent remains underexplored. OBJECTIVES: This study aimed to evaluate the antimicrobial and anti-biofilm activities of NDGA against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans, elucidate its mechanism of action, and assess its in vivo efficacy and biosafety. MATERIALS AND METHODS: NDGA's antimicrobial activities were assessed through MIC, time-kill, and biofilm disruption assays against standard and clinical isolates. Transcriptomic profiling and deep-learning-guided molecular docking were used to identify key microbial targets and regulatory pathways. In vivo efficacy was validated in Galleria mellonella and murine systemic infection models. Cytotoxicity, hemolysis, and acute toxicity assays were conducted to evaluate biosafety. RESULTS: NDGA exhibited potent antimicrobial activity, with MIC values of 32 μg/ml for S. aureus USA300 and 64 μg/ml for C. albicans SC5314. It effectively eradicated persister cells and disrupting mature biofilms of both MRSA and C. albicans. Transcriptomic analysis revealed that NDGA modulated multiple microbial virulence and biofilm-regulating pathways, including arginine biosynthesis in MRSA and ergosterol metabolism in C. albicans. Docking studies confirmed strong binding affinity of NDGA to critical microbial targets. In vivo, NDGA significantly improved survival rates, reduced pathogen burden, and alleviated tissue damage, showing comparable efficacy to vancomycin and fluconazole. NDGA demonstrated favorable biosafety with low cytotoxicity, minimal hemolysis, and no observable acute toxicity in mammalian models. CONCLUSION: NDGA is a promising antimicrobial candidate capable of disrupting biofilms and overcoming drug resistance in both bacterial and fungal infections. Its multitargeted mode of action, coupled with in vivo efficacy and biosafety, supports further development as a next-generation anti-infective agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Center for Membrane Receptor and Brain Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang Univers…
- Department of Pathology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China.
- College of Traditional Chinese Medicine, Binzhou Medical University, Yantai, 264003, China.
- Department of Gastroenterology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China.
- Department of Clinical Laboratory, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Yiwu, 322000, China.
- College of Basic Sciences, Shanxi Agricultural University, 1 Mingxian South Road, Taigu District, Jinzhong, 030801, China. Electronic address: lip@sxau.edu.cn.
Förderung
- Zhejiang University
Zitieren
APA
Fan, X., Dai, C., Han, J., Lou, S., Zhang, N., He, M., Zhu, Z., Li, P., Chen, X., & Xu, X. (2025). Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans. Phytomedicine, 148, 157265. https://doi.org/10.1016/j.phymed.2025.157265
Vancouver
Fan X, Dai C, Han J, Lou S, Zhang N, He M, et al. Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans. Phytomedicine. 2025;148:157265. doi:10.1016/j.phymed.2025.157265
BibTeX
@article{Fan2025,
author = {Fan, Xiangcheng and Dai, Chunyan and Han, Jichun and Lou, Shengying and Zhang, Ningjun and He, Minyang and Zhu, Zhiqiang and Li, Peng and Chen, Xingru and Xu, Xiaojun},
title = {Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans},
journal = {Phytomedicine},
year = {2025},
volume = {148},
pages = {157265},
doi = {10.1016/j.phymed.2025.157265}
}
EUVIMED